Collectively, these results suggest that the PRMT5-KCNMB4 axis plays a crucial role in mediating chemoresistance in NPC and targeting this axis may provide a promising therapeutic strategy for late-stage NPC patients. The gene discussed is KCNMB4; the disease is nasopharyngeal carcinoma.